Back to Gene
SHOX gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

SHOX gene

The SHOX gene is essential for normal skeletal development, particularly in the growth and maturation of bones in the arms and legs.

Normal Function

The SHOX gene provides instructions for making a protein that regulates the activity of other genes. On the basis of this role, the SHOX protein is called a transcription factor. The SHOX gene is part of a large family of homeobox genes, which act during early embryonic development to control the formation of many body structures. Specifically, the SHOX gene is essential for the development of the skeleton. It plays a particularly important role in the growth and maturation of bones in the arms and legs.

One copy of the SHOX gene is located on each of the sex chromosomes (the X and Y chromosomes) in an area called the pseudoautosomal region. Although many genes are unique to either the X or Y chromosome, genes in the pseudoautosomal region are present on both chromosomes. As a result, both females (who have two X chromosomes) and males (who have one X and one Y chromosome) have two functional copies of the SHOX gene in each cell.

Health Conditions Related to Genetic Changes

Langer mesomelic dysplasia

Langer mesomelic dysplasia results from genetic changes involving both copies of the SHOX gene in each cell. Deletions of this gene are the most common change responsible for this condition. Mutations in the SHOX gene can also cause the condition, as can deletions of nearby genetic material that normally helps regulate the gene's activity. These changes greatly reduce or eliminate the amount of SHOX protein that is produced. A lack of this protein disrupts normal bone development and growth starting before birth. The resulting skeletal abnormalities include:

  • Very short stature
  • Extreme shortening of the long bones in the arms and legs (mesomelia)
  • An abnormality of the wrist and forearm bones known as Madelung deformity

Léri-Weill dyschondrosteosis

Léri-Weill dyschondrosteosis results from genetic changes involving one copy of the SHOX gene in each cell. Most commonly, this skeletal disorder is caused by a deletion of the SHOX gene. Other genetic changes that can cause the disorder include mutations in the SHOX gene or deletions of nearby genetic material that normally helps regulate the gene's activity. These changes reduce the amount of SHOX protein that is produced. A shortage of this protein disrupts normal bone development and growth starting before birth. The resulting skeletal abnormalities are similar to those of Langer mesomelic dysplasia, although they tend to be less severe.

Turner syndrome

Turner syndrome occurs when one normal X chromosome is present in a female's cells and the other sex chromosome is missing or structurally altered. Because the SHOX gene is located on the sex chromosomes, most women with Turner syndrome have only one copy of the gene in each cell instead of the usual two copies. Loss of one copy of this gene reduces the amount of SHOX protein that is produced. A shortage of this protein likely contributes to the short stature and skeletal abnormalities (such as unusual rotation of the wrist and elbow joints) often seen in females with this condition.

Other disorders

Deletions of the entire SHOX gene or mutations within or near the gene have been identified in some people with short stature. This short stature is usually described as idiopathic, which means it is not associated with the characteristic features of a disease or syndrome. However, some people with short stature and changes in the SHOX gene have been found to have subtle skeletal abnormalities.

Frequently Asked Questions

Yes. Adults with disproportionate short stature, especially if they have a history of early‑onset growth failure, Madelung deformity, or a parent/relative with similar features, can benefit from SHOX testing. Identifying a pathogenic variant helps clarify the diagnosis, informs surveillance for orthopedic complications, and guides family planning.
Short stature caused by SHOX deficiency often presents with proportionally short arms and legs (mesomelic shortening), a relatively normal trunk length, and sometimes a high‑arched palate or Madelung deformity of the wrist. If a child’s height is more than 2 standard deviations below the mean and these skeletal features are present, clinicians usually order a chromosomal microarray or targeted SHOX testing to look for deletions or mutations.
SHOX is located in the pseudoautosomal region, so it follows an autosomal‑dominant pattern with sex‑independent transmission. Each child has a 50 % chance of inheriting the altered copy. However, expression can vary; some carriers have mild or no symptoms, while others show classic short stature. Genetic counseling is recommended to discuss recurrence risk and testing options for relatives.
The mainstay of treatment is recombinant human growth hormone (rhGH) therapy, which can increase final adult height by 5–10 cm when started before the growth plates close. Orthopedic monitoring for wrist or forearm deformities is also important; surgery may be needed for severe Madelung deformity. Regular endocrinology follow‑up ensures optimal dosing and monitors side effects.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ